Edition:
India

People: Impax Laboratories Inc (IPXL.OQ)

IPXL.OQ on NASDAQ Stock Exchange Global Select Market

20.40USD
2:29am IST
Change (% chg)

$0.70 (+3.55%)
Prev Close
$19.70
Open
$19.85
Day's High
$20.65
Day's Low
$19.50
Volume
234,306
Avg. Vol
279,945
52-wk High
$25.70
52-wk Low
$7.80

Nestor, Michael 

Mr. Michael J. Nestor is President - Impax Specialty Pharmaceutical Division of Impax Laboratories Inc. Before joining us, he has served as President of our branded products division, Impax Specialty Pharma, since March 2008. Before joining us, he was Chief Operating Officer of Piedmont Pharmaceuticals, a specialty pharmaceutical company, from July 2007 to March 2008. Prior to Piedmont, Mr. Nestor was CEO of NanoBio, a startup biopharmaceutical company from December 2004 to November 2006, prior to which he was employed by Alpharma, initially as President of its generic pharmaceutical business and later as President of its branded pharmaceutical business. Before Alpharma, he was President, International business at Banner Inc. a global contract manufacturing concern. Prior to Banner, Mr. Nestor spent 16 years at Lederle Laboratories / Wyeth holding increasing positions of responsibility including Vice President, Cardiovascular business, Vice President / General Manager of Lederle-Praxis Biologics, and Vice President of Wyeth-Lederle Vaccines and Pediatrics. Mr. Nestor has a Bachelor of Business Administration degree from Middle Tennessee State University and an MBA from Pepperdine University.

Basic Compensation

Total Annual Compensation, USD 548,908
Restricted Stock Award, USD 727,016
Long-Term Incentive Plans, USD --
All Other, USD 724,634
Fiscal Year Total, USD 2,000,560

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Burr

389,374

Paul Bisaro

--

Bryan Reasons

2,248,520

Douglas Boothe

2,499,380

Michael Nestor

2,000,560

Robert Stewart

--
As Of  31 Dec 2016